Send saliva test kits to your patients’ homes or order testing in your clinic.

For telehealth needs, it’s easy to order and send genetic test kits to patients at home. Get actionable results and access to our board-certified genetic counselors.

Get Started

Welcome to Color: affordable, accessible, and actionable

Medically actionable results

Reports integrate relevant guidelines to help you develop a personalized screening and prevention plan for your patients.

Patient focused genetic testing

Color’s low self-pay price and complimentary access to our genetic counselors make testing accessible for your patients.

Clinical-grade quality

Our validated test is performed in our CAP-accredited and CLIA-certified lab using Next Generation Sequencing methods and customized software tools.

Color partners with leading institutions.

Genetic Testing & Counseling

Color offers one of the most accessible, clinical-grade genetic testing services available today, analyzing genes associated with hereditary risk information around cancer and heart disease, and genes that can impact medication response. Our advanced lab is CAP-accredited and CLIA-certified, applying technologies to help ensure the integrity of the results we provide.

As part of every Color program, genetic counseling consultations are available to physicians and patients on an ongoing basis. Our team of board-certified genetic counselors provide a concierge-like experience – we answer questions, provide education, offer support to patients and their families, and consult directly with physicians and care teams to help ensure that results lead to actionable and relevant next steps.

Digital Activation and Engagement

We provide a suite of services, tools, and expertise to help you acquire new patients and activate them into care journeys relevant to them over time. We use a more complete view of patient health, incorporating an individual’s genetics, personal & family health history, and lifestyle & behavior information to surface and recommend specific care or point solutions that patients can take advantage of based on their personal risks.

This can include a range of relevant programs, from reminders about flu shots and annual wellness visits to getting breast and colon cancer screenings, as well as tools to help manage multiple chronic conditions like diabetes and high blood pressure.

Meet the Color provider community.

Our providers believe in improving the lives of their patients.

Dr. Adashek, MD and Chris – Lutherville Timonium, Maryland

Dr. Adashek is a practicing obstetrician-gynecologist with over 30 years of experience and Chris is one of his patients. Chris’s results from the Hereditary Cancer Test indicated that she had an increased risk for ovarian, uterine, and other cancers. This prompted Dr. Adashek to work with Chris on a personalized screening and prevention plan.

Color’s lab, team, and processes generate
results you can trust.

Our CAP-accredited and CLIA-certified laboratory uses the newest technology, including next generation sequencing, advanced liquid-handling robots, and customized software to ensure the integrity of our results.

Validated

Color performed blinded validation studies to assess the validity of our test, and all our genetic variants were detected with >99% accuracy. To read our validation white papers, published studies, and research posters, visit our Research page. 

Quality checked

The quality of every sample is checked multiple times as it moves through the sequencing and interpretation process. A certified scientist reviews every result before it is released.

State-of-the-art
variant classification

Our Ph.D. and M.D. scientists use state-of-the-art tools to classify variants according to American College of Medical Genetics and Genomics (ACMG) guidelines.

Secondary confirmations

Likely pathogenic and pathogenic variants, copy number variations, insertions, and inversions are confirmed by an alternative technology according to Color’s internal protocols.*

Giving back

We believe everyone has the right to benefit from their own genetic information. To help make that vision a reality, Color brings genetic testing to underserved communities through Color for All. Our nonprofit Color Foundation provides funding for students and scientists studying the role of genetics in human disease via Color Research Grants.

The Color Research team partners with some of the world’s top research hospitals and clinics, including UCSF, the University of Washington, and the University of Pennsylvania.

                 

Our advisors and collaborators

Mary-Claire King, Ph.D.

Geneticist and Professor of Genome Sciences and Medicine at the University of Washington. Advisor, Scientific Collaborator

Tom Walsh, Ph.D.

Research Associate Professor of Medical Genetics at the University of Washington. Advisor, Scientific Collaborator

Laura van’t Veer, Ph.D.

Molecular Biologist and leader of the Breast Oncology Program at the UCSF Cancer Center. Scientific Collaborator

Beth Crawford, M.S., L.C.G.C.

Director of Genetic Counseling at the UCSF Cancer Genetics and Prevention Program. Scientific Collaborator

Laura Esserman, M.D., M.B.A.

Breast surgeon and Director of the UCSF Carol Franc Buck Breast Care Center. Scientific Collaborator

Susan Domchek, M.D.

Executive Director for the Basser Center for BRCA at Penn’s Abramson Cancer Center. Scientific Collaborator

Iftikhar J. Kullo, M.D

Professor, College of Medicine, Mayo Clinic. Director FH and Early Atherosclerosis Clinics. Head, Atherosclerosis and Lipid Genomics Laboratory. Advisor, Scientific Collaborator

Steve Laszlo Bock

Former SVP of People Operations at Google and author of “Work Rules!” Advisor

Stan Lapidus

CEO, Founder of SynapDx. Teaches at MIT and holds over 30 issued US patents. Advisor

Have more questions? Visit Provider Support

* Certain exceptions apply. Variants will not be confirmed if, after testing, there is insufficient DNA available for secondary confirmation. Variants called at high confidence (color.com/variantconfidence) will be reported without secondary confirmation if the variant has been confirmed at least three times in previous carriers.